Article
Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis
28 Mar 2023
Abstract excerpt
INTRODUCTION: Although there are gold-standard diagnostic guidelines and effective treatments to slow the disease progression of rheumatoid arthritis (RA), approximately 40% of patients still do not respond adequately to their initial treatment. The identification of specific and sensitive biomarkers for early and accurate diagnosis and response to treatment is a clinical priority and could reduce the time to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
